Vendevia Group

 

Thomas Ichim, Ph.D.

Managing Partner

 

Dr. Ichim is a managing partner of Vendevia Group and provides scientific leadership in the review and oversight of potential and existing investments. Dr. Ichim is focused on leading Medistem and OncoMune, VG’s portfolio companies.  

 

Dr. Ichim is an accomplished immunologist, drug developer with numerous contributions to the biomedical sciences spanning over 16 years. He has authored dozens of patents and developed numerous novel therapeutics solutions primarily in oncology. Dr. Ichim has been responsible for technology development and served as the Chief Scientific Officer at such biotech firms as MedVax and MarrowTech Pharma.

Biomedical Venture Development

Boris Reznik, PhD

Chairman

 

Thomas Ichim, PhD

Managing Partner

 

Gary Reznik, MD

Managing Partner

 

Helen Picone, CPA

CFO and Controller

 

Paul Butler, Esq.

Advisory Board

 

Kurt Gehlsen, PhD,

Advisory Board

 

Eugene Golub,

Advisory Board

 

Russel Kaufman, MD,

Advisory Board

 

Robert Pearlman

Advisory Board